Zucker Hillside Hospital

Podcast personalizes opioid addiction, recovery

Things get real in this month’s edition of the Health Story podcast, which offers insights on the national opioid-addiction crisis. The latest installment of Northwell Health’s monthly series dives deep into one former patient’s journey of addiction and recovery – a cautionary tale about something that already victimizes Americans from every walk of life and “could happen to anyone,” according to the health system. In this case, it happened to New Yorker Jonathan Allen, who…


Opioid epidemic spurs new LI substance-abuse center

In a move aimed at combating what it called “the opioid epidemic sweeping the country,” the Northwell Health system has opened the doors of a new Long Island substance-abuse treatment center. The Garden City Treatment Center, located on Stewart Avenue in the Nassau County village, is managed by Zucker Hillside Hospital, which resides in Glen Oaks, just west of the Queens-Nassau border. But the focus of the 8,000-square-foot center, which officially opened this summer, is…


At Zucker Hillside, a new focus on behavioral crises

Reducing emergency room visits by patients suffering long-term psychiatric disorders is the main thrust of a new “crisis center” on the Nassau-Queens border. The Northwell Health system has cut the ribbon on its new Adult Behavioral Health Crisis Center at Zucker Hillside Hospital in Glen Oaks, part of “an ongoing effort to improve the quality of life of people living with psychiatric disorders,” according to Northwell. The center provides walk-in services to those needing immediate…


Researchers zoom in on schizophrenia biomarkers

A Feinstein Institute for Medical Research scientist will focus next-level imaging techniques on schizophrenia and other brain disorders, thanks to a hefty federal grant. Research scientist Anil Malhotra – a professor in the Feinstein Institute’s Center for Psychiatric Neuroscience and the Hofstra Northwell School of Medicine’s Department of Molecular Medicine – has been awarded a five-year, $3 million R01 grant from the National Institutes of Health to identify biomarkers specific to schizophrenia and treatment-resistant psychosis. The biomarkers…


Feinstein’s unexpected postpartum blessing

By GREGORY ZELLER // The Feinstein Institute for Medical Research has contributed to a potential breakthrough involving postpartum depression, a serious condition affecting hundreds of thousands of new mothers. Kristina Deligiannidis, an associate professor at the Feinstein Institute and the Hofstra Northwell School of Medicine, joined colleagues at the University of Massachusetts Medical School and Tufts University’s Cummings School of Veterinary Medicine on a study that indicates synthetic oxytocin – a common medication administered during…